GIROCOVATEIN

UNII:	BAA4CV6ACY
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	GIROCOVATEIN
GSRS Full Record:	BAA4CV6ACY i

3038651-03-2
316-533-Spike glycoprotein [533-glycine] (severe acute respiratory syndrome coronavirus 2 variant JN.1 precursor) fusion protein with 316-533-spike glycoprotein (severe acute respiratory syndrome coronavirus 2 variant JN.1 precursor)
Girocovatein
girocovatein [INN]
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), omicron lineage JN.1 (Gisaid: EPI_ISL_18872762) spike (S) glycoprotein receptor binding domain (RBD) fragment (303-520, 1-218 in the current sequence), variant (K520>G218) fused to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), omicron lineage JN.1 spike (S) glycoprotein receptor binding domain (RBD) fragment (303-520, 219-436 in the current sequence, K436>del), single chain homodimer, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

GIROCOVATEIN

Synonyms and Mappings

Resources